Time to Reassess the Cancer Compendia for Off-label Drug Coverage in Oncology-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Time to Reassess the Cancer Compendia for Off-label Drug Coverage in Oncology

Published:2016-10-18 Issue:15 Volume:316 Page:1541
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Green Angela K.¹,Wood William A.¹,Basch Ethan M.²

Affiliation:

1. Cancer Outcomes Research Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill

2. Cancer Outcomes Research Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill2Associate Editor, JAMA

Publisher

American Medical Association (AMA)

Subject

General Medicine

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Benefit and Regulatory Outcomes of Cancer Drugs Receiving Accelerated Approval;JAMA;2024-05-07

2. National Comprehensive Cancer Network Guideline Recommendations of Cancer Drugs With Accelerated Approval;JAMA Network Open;2023-11-14

3. Quantifying absolute benefit for adjuvant treatment options in renal cell carcinoma: A living interactive systematic review and network meta-analysis;Critical Reviews in Oncology/Hematology;2022-07

4. Factors Associated With Off-Label Oncology Prescriptions: The Role of Cost and Financing in a Universal Healthcare System;Frontiers in Pharmacology;2021-10-19

5. Personal Payments from Pharmaceutical Companies to Authors of Oncology Clinical Practice Guidelines;The Oncologist;2021-05-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP